Abstract
Amebiasis is extraordinarily common in children of the developing world. This realization has come from application of diagnostic techniques that distinguish the nonpathogenic parasite Entamoeba dispar from Entamoeba histolytica. E. histolytica infection is found in children with dysentery, diarrhea, and in many cases in children with no gastrointestinal symptoms. Genetically distinct strains of E. histolytica exist but evidence is too preliminary to judge if some strains are more virulent than others. A provocative study from Tanzania has shown that pregnant women with HIV infection who are coinfected with E. histolytica are at greater risk of delivering a low birth weight infant. Perhaps the most exciting new data is the identification of acquired immunity to recurrent E. histolytica infection. Acquired immunity is linked to a mucosal immune response against a major virulence factor of the parasite, a Gal/GalNAc lectin responsible for adherence and killing of the host. Prospects for a vaccine are thus brightening at the same time that the true burden of disease is comprehended.
Article PDF
Similar content being viewed by others
References and Recommended Reading
Katz DE, Taylor DN: Parasitic infections of the gastrointestinal tract. Gastroenterol Clin North Am 2001, 30:797–815.
Haque R, Ali IKM, Sack RB, et al.: Amebiasis and mucosal IgA antibody against the Entamoeba histolytica adherence lectin in Bangladeshi children. J Infect Dis 2001, 183:1787–1793. Preschool-aged children from a slum community in Dhaka, Bangladesh were prospectively studied for new E. histolytica infections for 1 year. Stool IgA antibodies and serum IgG antibodies against the parasite’s Gal/GalNAc adherence lectin were measured, and E. histolytica infection was detected through monthly stool culture and antigen detection tests. A stool antilectin IgA response was associated with the absence of E. histolytica colonization, and with a 64% lower incidence of new infection at 5 months of observation. Surprisingly, a serum IgG antilectin response was associated with a higher rate of new E. histolytica infection.
Schunk M, Jelinek T, Wetzel K, Nothdurft HD: Detection of Giardia lamblia and Entamoeba histolytica in stool samples by two enzyme immunoassays. Eur J Clin Microbiol Infect Dis 2001, 20:389–391.
Sharp SE, Suarez CA, Duran Y, Poppiti RJ: Evaluation of the Triage Micro Parasite Panel for detection of Giardia lamblia, Entamoeba histolytica/Entamoeba dispar, and Cryptosporidium parvum in patient stool specimens. J Clin Microbiol 2001, 39:332–334.
Lee MB, Keystone JS, Kain KC: Nonpathogenic protozoa: laboratory reporting practices in Canada and the United States. Lab Med 2001, 32:455–456. Reporting the identification of nonpathogenic protozoa without notation of their lack of medical significance is a common problem.
Zaki M, Clark CG: Isolation and characterization of polymorphic DNA from Entamoeba histolytica. J Clin Microbiol 2001, 39:897–905.
Ayeh-Kumi P, Ali IKM, Lockhart L, et al.: Entamoeba histolytica: genetic diversity of clinical isolates from Bangladesh as demonstrated by polymorphisms in the serine-rich gene. Exp Parasitol 2002, In press.
Braga LL, Gomes ML, Da Silva MW, et al.: Household epidemiology of Entamoeba histolytica infection in an urban community in northeastern Brazil. Am J Trop Med Hyg 2001, 65:268–271. The authors studied E. histolytica infection in urban slum communities of northeastern Brazil using stool antigen detection tests. Almost all families with an index case of amebiasis had at least one additional family member who was E. histolytica infected. Most (70%) infections were not associated with diarrhea but were self-limited.
Valenzuela O, Ramos F, Morán P, et al.: Persistence of secretory antiamoebic antibodies in patients with past invasive intestinal or hepatic amoebiasis. Parasitol Res 2001, 87:849–852. Anti-amebic antibody responses were measured in 39 patients with amebic colitis and liver abscess. Serum IgG antibodies were detected in 70% of colitis and 100% of liver abscess patients. Supporting the presence of distinct mucosal and systemic immune responses to the ameba, there was no correlation between salivary IgA and serum IgG antibody responses. The salivary IgA response was detected up to 12 months after infection. Only one of the 39 patients had a second episode of invasive amebiasis during 1 year of observation, suggesting the presence of acquired immunity.
Cheng X-J, Hughes MA, Huston CD, et al.: Intermediate subunit of the Gal/GalNAc lectin of Entamoeba histolytica is a member of a gene family containing multiple CXXC sequence motifs. Infect Immun 2001, 69:5892–5898.
EichingerD: A role for a galactose lectin and its ligands during encystment of Entamoeba. J Eukaryot Microbiol 2001, 48:17–21. This soon to be classic paper reports that the formation of the infectious cyst form of the parasite requires the parasite galactose lectin.
Kasper LH, Buzoni-Gatel D: Ups and downs of mucosal cellular immunity against protozoan parasites. Infect Immun 2001, 69:1–8. Review article that synthesizes the vast amount of information about innate and acquired cellular mucosal immune responses against the protozoan parasites G. lamblia, C. parvum, Toxoplasma gondii, E. histolytica, and Eimeria species.
Stanley SL Jr: Protective immunity to amebiasis: new insights and new challenges. J Infect Dis 2001, 184:504–506. Timely and comprehensive overview of immune responses to amebiasis and vaccine research.
Amano K, Takeuchi T: Amebiasis in acquired immunodeficiency syndrome [editorial]. Intern Med 2001, 40:563–564.
Mitarai S, Nagai H, Satoh K, et al.: Amebiasis in Japanese homosexual men with human immunodeficiency virus infection. Intern Med 2001, 40:671–675.
Liu CJ, Hung CC, Chen MY, et al.: Amebic liver abscess and Human Immunodeficiency Virus infection: a report of three cases. J Clin Gastroenterol 2001, 33:64–68.
Taki T, Imazu H, Miyamoto Y, et al.: A case of amebic liver abscess in a homosexual man [in Japanese]. J Nara Med Assoc 2001, 52:24–28.
Dreyfuss ML, Msamanga GI, Spiegelman D, et al.: Determinants of low birth weight among HIV-infected pregnant women in Tanzania. Am J Clin Nutr 2001, 74:814–826. First study to examine the role of parasitic coinfections on low birth weight infants from HIV-infected mothers. E. histolytica was found to have a greater impact than any other parasite tested.
Upcroft JA, Upcroft P: Drug targets and mechanisms of resistance in the anaerobic protozoa. Clin Microbiol Rev 2001, 14:150–164. Excellent review of drug resistance in Trichomonas vaginalis, G. lamblia, and E. histolytica by a husband and wife team who are the world’s experts.
Upcroft JA, Upcroft P: Drug susceptibility testing of anaerobic protozoa. Antimicrob Agents Chemother 2001, 45:1810–1814.
Rossignol JF, Ayoub A, Ayers MS: Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of Nitazoxanide. J Infect Dis 2001, 184:381–384. Convincing demonstration of the potential utility of nitazoxanide for both giardiasis and amebiasis.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Petri, W.A. Entamoeba histolytica: Clinical update and vaccine prospects. Curr Infect Dis Rep 4, 124–129 (2002). https://doi.org/10.1007/s11908-002-0052-9
Issue Date:
DOI: https://doi.org/10.1007/s11908-002-0052-9